Your browser doesn't support javascript.
loading
A Phase 2 Randomized Trial of a Rifapentine plus Moxifloxacin-Based Regimen for Treatment of Pulmonary Tuberculosis.
Conde, Marcus B; Mello, Fernanda C Q; Duarte, Rafael Silva; Cavalcante, Solange C; Rolla, Valeria; Dalcolmo, Margareth; Loredo, Carla; Durovni, Betina; Armstrong, Derek T; Efron, Anne; Barnes, Grace L; Marzinke, Mark A; Savic, Radojka M; Dooley, Kelly E; Cohn, Silvia; Moulton, Lawrence H; Chaisson, Richard E; Dorman, Susan E.
Afiliação
  • Conde MB; Instituto de Doenças do Tórax, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
  • Mello FC; Instituto de Doenças do Tórax, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
  • Duarte RS; Instituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
  • Cavalcante SC; Municipal Health Secretariat, Rio de Janeiro, Brazil.
  • Rolla V; Instituto Nacional de Infectologia Evandro Chagas, Fiocruz, Rio de Janeiro, Brazil.
  • Dalcolmo M; Instituto Nacional de Infectologia Evandro Chagas, Fiocruz, Rio de Janeiro, Brazil.
  • Loredo C; Centro de Referência Hélio Fraga, Ministério da Saúde, Fiocruz Rio de Janeiro, Brazil.
  • Durovni B; Instituto de Doenças do Tórax, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
  • Armstrong DT; Municipal Health Secretariat, Rio de Janeiro, Brazil.
  • Efron A; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
  • Barnes GL; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
  • Marzinke MA; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
  • Savic RM; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
  • Dooley KE; University of California San Francisco, San Francisco, California, United States of America.
  • Cohn S; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
  • Moulton LH; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
  • Chaisson RE; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
  • Dorman SE; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
PLoS One ; 11(5): e0154778, 2016.
Article em En | MEDLINE | ID: mdl-27159505
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Rifampina / Tuberculose Pulmonar / Fluoroquinolonas / Antituberculosos Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Brasil
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Rifampina / Tuberculose Pulmonar / Fluoroquinolonas / Antituberculosos Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Brasil